| |
Pearson correlation |
Fisher-z |
| All adjusted for AB42 |
CC |
EM |
MI |
CC |
EM |
MI |
| WBV and RD Genu (n) |
123 |
186 |
185 |
123 |
186 |
185 |
| Coef |
-0.162 |
-0.239 |
-0.261 |
-0.164 |
-0.243 |
-0.279 |
| SE |
0.090 |
0.076 |
0.083 |
0.092 |
0.080 |
0.085 |
| p-value |
0.074 |
0.002 |
0.007 |
0.074 |
0.002 |
0.006 |
| WBV and FA Genu (n) |
123 |
186 |
185 |
123 |
186 |
185 |
| Coef |
0.131 |
0.170 |
0.202 |
0.132 |
0.172 |
0.184 |
| SE |
0.090 |
0.098 |
0.088 |
0.092 |
0.101 |
0.084 |
| p-value |
0.15 |
0.085 |
0.039 |
0.15 |
0.09 |
0.046 |
| WBV and PIB (n) |
132 |
186 |
168 |
132 |
186 |
168 |
| Coef |
0.022 |
0.028 |
0.040 |
0.022 |
0.028 |
0.047 |
| SE |
0.088 |
0.083 |
0.083 |
0.088 |
0.074 |
0.083 |
| p-value |
0.80 |
0.74 |
0.63 |
0.80 |
0.74 |
0.57 |
Note: full data (Full), complete case analysis (CC), the expectation-maximization algorithm (EM), multiple imputation (MI), cerebrospinal fluid amyloid beta peptide 42 (AB42), whole brain volume (WBV), corpus callosum genu region (Genu),radial diffusivity (RD), fractional anisotropy (FA), and Pittsburgh Compound B (PIB) |
